Clinical Trial Update: Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inhaled corticosteroids for treating Transient Tachypnea of the Newborn; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Tachypnea of the Newborn

Snippet

Sponsor: Bnai Zion Medical Center | Conditions: Transient Tachypnea of the Newborn | Phase 2 | Status: UNKNOWN